Illumina ILMN
NASDAQ ILMN
$245.18 +16.25 (+7.10%)
At close: Sep 17, 2026 · 4:00 PM EDT

Illumina (ILMN) Net Equity Issued and Repurchased (2009 - 2026)

Illumina's (ILMN) quarterly Net Equity Issued and Repurchased came in at $24.0 million in Q1 2026, down 11.11% on a YoY basis from $27.0 million in Q1 2025, and up 50.0% quarter-over-quarter from $16.0 million in Q3 2025.

Analysis

Illumina (ILMN) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends

Illumina (ILMN) has reported Net Equity Issued and Repurchased for 18 consecutive years, with $24.0 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Net Equity Issued and Repurchased fell 11.11% year-over-year to $24.0 million; the trailing twelve-month figure through Jun 2026 stood at $40.0 million (down 16.67% YoY), and the FY2025 full-year result was $44.0 million, down 21.43% from the prior year.
  • Net Equity Issued and Repurchased advanced to $24.0 million in Q1 2026 per ILMN's latest filing, from $16.0 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $37.0 million in Q2 2023 and bottomed at $1.0 million in Q2 2025.
  • Historically, Net Equity Issued and Repurchased has averaged $22.8 million across 5 years, with a median of $25.5 million in 2025.
  • The sharpest annual moves came in 2023 and 2024: Net Equity Issued and Repurchased gained 12.12% in 2023, then slumped 33.33% in 2024.
  • Over 5 years, Net Equity Issued and Repurchased stood at $33.0 million in 2022, then fell by 9.09% to $30.0 million in 2023, then slumped by 33.33% to $20.0 million in 2024, then declined by 20.0% to $16.0 million in 2025, then soared by 50.0% to $24.0 million in 2026.
  • According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $24.0 million, $16.0 million, and $1.0 million for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn -
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn -
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 4.20 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 29, 2026 24.00 Mn
Sep 28, 2025 16.00 Mn
Jun 29, 2025 1.00 Mn
Mar 30, 2025 27.00 Mn
Sep 29, 2024 20.00 Mn
Mar 31, 2024 36.00 Mn
Oct 1, 2023 30.00 Mn
Apr 2, 2023 37.00 Mn
Jan 1, 2023 4.00 Mn
Apr 3, 2022 33.00 Mn
Oct 3, 2021 28.00 Mn
Apr 4, 2021 31.00 Mn
Sep 27, 2020 27.00 Mn
Jun 28, 2020 2.00 Mn
Mar 29, 2020 32.00 Mn
Sep 29, 2019 29.00 Mn
Jun 30, 2019 3.00 Mn
Mar 31, 2019 27.00 Mn
Dec 30, 2018 1.00 Mn
Sep 30, 2018 23.00 Mn